Next Generation Sequencing (NGS) Market Poised to Hit $42.25 Billion by 2033: Key Drivers Behind the Surge - Latest Study by Grand View Research, Inc.
The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...
EHE treatment is highly individualized, involving surgery, ablation, chemotherapy, and mTOR inhibitors, depending on patient-specific factors. Next-generation sequencing helps identify genetic ...
Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced presentations demonstrating the clinical impact of using its flagship metagenomic ...
Agilent Technologies introduced SureSelect Human All-Exon V5 and V5 + UTRs for next-generation sequencing. The new all-exon solutions incorporate the latest advances from Agilent Genomics, the ...
The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth ...
Key opportunities in the precision oncology market include the rising adoption of personalized therapies, growth in ...
1don MSN
New 'ultra-mild' sequencing method fixes long-standing flaws in cancer DNA methylation tests
Traditional bisulfite sequencing damages DNA, while enzyme-based alternatives are inconsistent. A novel methylation analysis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback